Compare Chubb Ltd (CB) vs Quest Diagnostics Inc (DGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Chubb Ltd vs Quest Diagnostics Inc — how do they compare? Chubb Ltd trades at $346.57 (market cap $134.37B), while Quest Diagnostics Inc trades at $237.5 (market cap $26.23B). The key difference: Chubb Ltd is far larger — about 5.1× Quest Diagnostics Inc's market cap, and Quest Diagnostics Inc pays the higher dividend (1.45%). Which is the better fit depends on your goals.
| CB | DGX | |
|---|---|---|
Market Cap | $134.37B | $26.23B |
Sector | Financials | Health |
52-Week High | $363.50 | $238.50 |
52-Week Low | $268.20 | $173.49 |
Enterprise Value | $155.22B | $31.99B |
Dividend Yield | 1.17% | 1.45% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Chubb Ltd
ACE acquired Chubb in the first quarter of 2016 and assumed the Chubb name. The combination makes the new Chubb one of the largest domestic property and casualty insurers, with operations in 54 countries spanning commercial and personal P&C insurance, reinsurance, and life insurance.
Read more on CB →About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →
